Bioniz Therapeutics

Bioniz is an emerging biotechnology/drug development company focused on discovering small peptides and molecules for the treatment of autoimmune diseases and some forms of cancer. Bioniz mission is to complete proof of concept and preclinical studies of its lead technology and seek partners to conduct clinical trials for regulatory approval and commercialization.

At Bioniz, they are committed to the discovery of novel molecules that enhance the lives of people across the globe. They perform our research with integrity and conscious, and bear in mind always our responsibility to the public health and their investors.

It was founded in 2009 and headquartered in Irvine, California.

Bioniz Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device sector. The company focuses on Biotechnology and has secured $515.4M in funding across 36 round(s). With a team of 11-50 employees, Bioniz Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Bioniz Therapeutics, raised $599.2K. Discover more about their projects, partnerships, and impact on our platform.